References
- Mármol I, Sánchez-de-Diego C, Pradilla Dieste A, Cerrada E, Rodriguez Yoldi MJ. Colorectal carcinoma: a general overview and future perspectives in colorectal cancer. Int J Mol Sci. 2017;18(1):197. Published 2017 Jan 19. doi:https://doi.org/10.3390/ijms18010197.
- Chi Y, Zhou D. MicroRNAs in colorectal carcinoma-from pathogenesis to therapy. J Exp Clin Cancer Res. 2016;35:43. Published 2016 Mar 10. doi:https://doi.org/10.1186/s13046-016-0320-4.
- Miller KG, Field CM, Alberts BM. Actin-binding proteins from Drosophila embryos: a complex network of interacting proteins detected by F-actin affinity chromatography. J Cell Biol. 1989;109(6 Part 1):2963–2975. doi:https://doi.org/10.1083/jcb.109.6.2963.
- Oegema K, Savoian MS, Mitchison TJ, Field CM. Functional analysis of a human homologue of the Drosophila actin binding protein anillin suggests a role in cytokinesis. J Cell Biol. 2000;150(3):539–552. doi:https://doi.org/10.1083/jcb.150.3.539.
- Piekny AJ, Glotzer M. Anillin is a scaffold protein that links RhoA, actin, and myosin during cytokinesis. Curr Biol. 2008;18(1):30–36. doi:https://doi.org/10.1016/j.cub.2007.11.068.
- Wang Z, Chen J, Zhong MZ, et al. Overexpression of ANLN contributed to poor prognosis of anthracycline-based chemotherapy in breast cancer patients. Cancer Chemother Pharmacol. 2017;79(3):535–543. doi:https://doi.org/10.1007/s00280-017-3248-2.
- Schiewek J, Schumacher U, Lange T, et al. Clinical relevance of cytoskeleton associated proteins for ovarian cancer. J Cancer Res Clin Oncol. 2018;144(11):2195–2205. doi:https://doi.org/10.1007/s00432-018-2710-9.
- Suzuki C, Daigo Y, Ishikawa N, et al. ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway. Cancer Res. 2005;65(24):11314–11325. doi:https://doi.org/10.1158/0008-5472.CAN-05-1507.
- Wang G, Shen W, Cui L, Chen W, Hu X, Fu J. Overexpression of anillin (ANLN) is correlated with colorectal cancer progression and poor prognosis. Cancer Biomark. 2016;16(3):459–465. doi:https://doi.org/10.3233/CBM-160585.
- Spangle JM, Roberts TM, Zhao JJ. The emerging role of PI3K/AKT-mediated epigenetic regulation in cancer. Biochim Biophys Acta Rev Cancer. 2017;1868(1):123–131. doi:https://doi.org/10.1016/j.bbcan.2017.03.002.
- Guo H, German P, Bai S, et al. The PI3K/AKT pathway and renal cell carcinoma. J Genet Genomics. 2015;42(7):343–353. doi:https://doi.org/10.1016/j.jgg.2015.03.003.
- Delire B, Stärkel P. The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications. Eur J Clin Invest. 2015;45(6):609–623. doi:https://doi.org/10.1111/eci.12441.
- Zhu Y, Cui J, Liu J, Hua W, Wei W, Sun G. Sp2 promotes invasion and metastasis of hepatocellular carcinoma by targeting TRIB3 protein. Cancer Med. 2020;9(10):3592–3603. doi:https://doi.org/10.1002/cam4.2977.
- Zhao LY, Yao Y, Han J, et al. miR-638 suppresses cell proliferation in gastric cancer by targeting Sp2. Dig Dis Sci. 2014;59(8):1743–1753. doi:https://doi.org/10.1007/s10620-014-3087-5.
- Lambert SA, Jolma A, Campitelli LF, et al. The human transcription factors [published correction appears in Cell. 2018 Oct 4;175(2):598–599]. Cell. 2018;172(4):650–665. doi:https://doi.org/10.1016/j.cell.2018.01.029.